The evolution of drug discovery: from phenotypes to targets, and back-Reference-Cited by-同舟云学术

The evolution of drug discovery: from phenotypes to targets, and back

Published:2016 Issue:5 Volume:7 Page:788-798
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Al-Ali Hassan¹²³⁴

Affiliation:

1. Miami Project to Cure Paralysis

2. University of Miami Miller School of Medicine

3. Miami FL 33136

4. USA

Abstract

Cumulative scientific and technological advances over the past two centuries have transformed drug discovery from a largely serendipitous process into the high tech pipelines of today.

Funder

National Institutes of Health

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/MD/C6MD00129G

Reference131 articles.

1. An overview of FDA-approved new molecular entities: 1827–2013

2. T. A. Ban , Neuropsychopharmacology and the history of pharmacotherapy in psychiatry , Reflections twentieth-century Psychopharmacol , Animula , Budapest , 2004 , pp. 697–720

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Feasibility Test of the Disposable Drug Daughter Plate Combined with 384‐Pillar Plate for Patient‐Derived Organoid‐Based High Throughput Screening;Advanced Therapeutics;2024-03-15

2. Reductionism and proxy failure: From neuroscience to target-based drug discovery;Behavioral and Brain Sciences;2024

3. Pharmacogenetics and pharmacogenomics;Biochemical and Molecular Pharmacology in Drug Discovery;2024

4. Models and approaches to comprehend and address glial inflammation following spinal cord injury;Drug Discovery Today;2023-10

5. Deep learning in image-based phenotypic drug discovery;Trends in Cell Biology;2023-07